2010
DOI: 10.1373/clinchem.2010.146035
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring of Therapy in Congenital Adrenal Hyperplasia

Abstract: BACKGROUND:Congenital adrenal hyperplasia is a group of disorders caused by defects in the adrenal steroidogenic pathways. In its most common form, 21-hydroxylase deficiency, patients develop varying degrees of glucocorticoid and mineralocorticoid deficiency as well as androgen excess. Therapy is guided by monitoring clinical parameters as well as adrenal hormone and metabolite concentrations. CONTENT:We review the evidence for clinical and biochemical parameters used in monitoring therapy for congenital adren… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
49
0
4

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 66 publications
(57 citation statements)
references
References 52 publications
4
49
0
4
Order By: Relevance
“…Diurnal 17OHP curves with dried blood spots can also be used to adjust glucocorticoid doses. Unfortunately, target concentrations are not clearly defined (42).…”
Section: Discussionmentioning
confidence: 99%
“…Diurnal 17OHP curves with dried blood spots can also be used to adjust glucocorticoid doses. Unfortunately, target concentrations are not clearly defined (42).…”
Section: Discussionmentioning
confidence: 99%
“…A total of Ͼ150 CYP21A2 mutations are currently reported, of which at least 97 are the missense type. Although CYP21A2 has been the subject of biochemical studies for the past several decades by clinical evaluation of patients and/or by measuring enzyme activities of recombinant proteins in cultured cells (8) and by structural prediction using different homology models (9, 10) based on other known P450 structures, many aspects of CYP21A2 biochemistry and especially the structural basis of the mutants causing CAH remain poorly understood (11)(12)(13)(14).…”
mentioning
confidence: 99%
“…Increase in pigmentation and deviation of the growth centile (length) with an increase in 17 OHP indicate inadequate hydrocortisone replacement whereas cushingoid facies with a suboptimal growth velocity would indicate over treatment (1,6).…”
Section: Clinical Features and Anthropometrymentioning
confidence: 99%